1.
Dataset.
2.
Descriptive characteristics per group at baseline (Mean ± SD or Median [IQR], except for sex).
Pain intensity and analgesic use per group and for total sample before the first treatment (T0), after the last treatment (T1) and at follow-up (T2) (Mean ± SD or Median [IQR]).
Secondary outcomes per group and for total sample before the first treatment (T0), after the last treatment (T1) and at follow-up (T2) (Median [IQR]).
Parameter estimates of the fixed effects of the final model predicting pain intensity.
DataSheet1_Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers.PDF
3.
4.
5.
6.
7.
DataSheet_1_Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature.docx
Baseline characteristics of the study population stratified by health status.
HRs [95% CI] for the adverse outcomes by total MVPA.
Baseline patient characteristics at the first questionnaire.